Christopherd T. Guiffre - Dec 3, 2021 Form 4 Insider Report for Pear Therapeutics, Inc. (PEARQ)

Role
CFO, COO, Treas., & Asst. Sec.
Signature
/s/ Stacie S. Aarestad, Attorney-in-Fact
Stock symbol
PEARQ
Transactions as of
Dec 3, 2021
Transactions value $
$0
Form type
4
Date filed
12/7/2021, 04:24 PM
Next filing
Feb 18, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PEARQ Stock Option (Right to Buy) Award +479K 479K Dec 3, 2021 Common Stock 479K $0.68 Direct F1, F2
transaction PEARQ Stock Option (Right to Buy) Award +51.5K 51.5K Dec 3, 2021 Common Stock 51.5K $0.72 Direct F3, F4
transaction PEARQ Stock Option (Right to Buy) Award +103K 103K Dec 3, 2021 Common Stock 103K $1.08 Direct F5, F6
transaction PEARQ Stock Option (Right to Buy) Award +243K 243K Dec 3, 2021 Common Stock 243K $1.09 Direct F7, F8
transaction PEARQ Stock Option (Right to Buy) Award +228K 228K Dec 3, 2021 Common Stock 228K $1.29 Direct F9, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option vested or shall vest on December 7, 2018 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each one month period thereafter.
F2 Received in accordance with the terms of the Business Combination Agreement (the "Business Combination Agreement") dated as of June 21, 2021, by and among Thimble Point Acquisition Corp., Oz Merger Sub, Inc. and Pear Therapeutics (US), Inc. (f/k/a Pear Therapeutics, Inc.) ("Private Pear"), in exchange for an option to acquire 325,000 shares of common stock of Private Pear for $1.00 per share.
F3 25% of the shares underlying the option vested or shall vest on December 7, 2018 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each one month period thereafter.
F4 Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 35,000 shares of common stock of Private Pear for $1.05 per share.
F5 25% of the shares underlying the option vested or shall vest on March 14, 2020 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
F6 Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 70,000 shares of common stock of Private Pear for $1.58 per share.
F7 25% of the shares underlying the option vested or shall vest on March 24, 2021 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
F8 Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 165,000 shares of common stock of Private Pear for $1.60 per share.
F9 25% of the shares underlying the option vested or shall vest on January 26, 2022 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
F10 Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 155,000 shares of common stock of Private Pear for $1.89 per share.